Health Payer Intelligence October 16, 2023
Victoria Bailey

Around 42 percent of Medicare Advantage plans received 2024 star ratings of four or higher, down from 51 percent in 2023.

The average star ratings for Medicare Advantage and Medicare Part D prescription drug plans fell for the second year in a row to 4.04 and 3.11 stars, respectively, CMS data revealed.

The star rating system uses a five-star scale to measure the quality of Medicare Advantage and Part D plans, with one being the lowest and five being the highest score. The score primarily reflects performance on consumer satisfaction and care quality measures.

The methodology for 2024 star ratings changed slightly with the addition of two new Part C measures on care transitions and follow-up care, the removal of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Insurance, Medicare Advantage, Provider
Growth in Medicare Advantage Raises Concerns
Study reveals cost differences between Medicare Advantage and traditional Medicare patients in cancer drugs
CMS proposes $21B payment increase for Medicare Advantage in 2026: 10 notes
Medicare Advantage leads to lower cancer drug costs in colorectal cancer
A Stronger Medicare Program—Now And Into The Future

Share This Article